Navigation Links
Angioplasty Outcomes May Vary Little Between Hospitals
Date:11/24/2009

In-hospital death rates didn't differ greatly between high- and low-volume centers, study found

TUESDAY, Nov. 24 (HealthDay News) -- Do hospitals that conduct the most angioplasties necessarily produce the best results for patients? Maybe not.

Prior research had suggested that "practice makes perfect" when it comes to artery-opening procedures, but a new study involving over 30,000 patients finds low- and high-volume hospitals performing more or less equally.

The study included patients with what are called primary angioplasties, cared for at 166 hospitals across the United States between 2001 and 2007.

The researchers found no significant difference in outcome between medical centers that did high volumes of such procedures and those that didn't do all that many.

"The message here is that volume alone is not a sufficient target marker for outcome," said study senior author Dr. Deepak Bhatt, chief of cardiology at the VA Boston Healthcare System and associate professor of medicine at Harvard Medical School. His team reported the findings in the Nov. 25 issue of the Journal of the American Medical Association.

Studies done several years ago did find better results at high-volume hospitals, "but I think things have changed," Bhatt said. "Devices and techniques, and overall results have improved."

Hospitals were classified in three groups: low-volume, with fewer than 36 primary angioplasties a year; middle-volume, between 36 and 70 procedures; and high-volume, with 70 or more procedures a year.

The in-hospital death rate was 3 percent for high-volume hospitals, 3.2 percent for medium-volume hospitals and 3.9 percent for low-volume hospitals, a difference that is not statistically significant, the report said.

The length of hospital stays was virtually the same for all hospitals: 4.6 days for low-volume, 4.5 days for medium-volume, 4.7 days for high-volume. But there was a difference in the interval between arrival at the hospital and beginning of angioplasty: 98 minutes for low-volume hospitals, 90 minutes for medium-volume and 88 minutes for high-volume. And high-volume hospitals were more likely to fulfill the guideline recommending start of an angioplasty within 90 minutes of arrival at a hospital.

Overall, the new findings are "really good news for patients in general, because it means that whatever hospital you go to, the result is likely to be good," said Dr. Issam D. Moussa, associate professor of medicine and director of the endovascular service at Weill Medical College of Cornell University, New York City, and a spokesman for the Society for Cardiovascular Angiography and Interventions.

The study results also confirm current guidelines about emergency treatment for heart attacks, Moussa said. "When they pick you up, they should take you to the nearest hospital," he said. "This study doesn't change that."

But he also said the findings of the study were not unshakable because of the relatively small number of people treated in low-volume hospitals.

"Low-volume hospitals [in the study] included only 3,000 patients," Moussa said. "Because of that low number, the results cannot be conclusive."

The difference between in-hospital death rates found in the study might have been statistically significant had the numbers been higher, he said. And the study also excluded about 120 hospitals because they reported too few primary angioplasties, Moussa said.

The study also looked only at in-hospital deaths, Bhatt noted. "If we looked at longer-term outcomes, differences might emerge," he said.

Still, the study casts some doubt on the notion that in cardiology, practice makes perfect, Bhatt noted. "Within the range we studied and the kinds of hospitals we studied, the difference was not there," he said.

In a related study published in the same issue of the journal, Norwegian researchers say that giving out-of-hospital cardiac arrest patients intravenous epinephrine therapy does not boost long-term survival.

A team from Oslo University compared outcomes for over 850 patients experiencing out-of-hospital cardiac arrest. Half received standard IV epinephrine as part of advanced cardiac life support, while the other half did not. The team found that about 10 percent of patients survived to hospital discharge, whether or not they had received the IV treatment.

More information

Emergency treatments for heart attacks are described by the U.S. National Heart, Lung and Blood Institute.



SOURCES: Deepak Bhatt, M.D., chief, cardiology, VA Boston Healthcare System, associate professor, medicine, Harvard Medical School, Boston; Issam D. Moussa, M.D., associate professor, medicine, director, endovascular service, Weill Medical College of Cornell University, New York City; Nov. 25, 2009, Journal of the American Medical Association


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Certain Reflux Drugs Tied to Higher Post-Angioplasty Death Rate
2. Mayo study shows stroke incidence related to angioplasty remains steady over past 15 years
3. American Heart Association Late Breaking Clinical Trial Report: Tests Predict Which Patients Are Resistant to Anti-Clotting Therapy During Angioplasty, Stenting
4. Sometimes Angioplasty Can Wait
5. Surgery Better Than Angioplasty for Narrowed Neck Artery
6. State Report Ranks LIJ as New Yorks Best for Heart Bypass Surgery, North Shore University Hospital Tops for Emergency Angioplasty Survival
7. Quick Angioplasty Best After Heart Attacks
8. Breaking medical and scientific news in angioplasty to be presented in San Francisco at TCT 2009
9. Nurses: Providing angioplasty patient care in and out of the cath lab
10. Racial Disparity Seen in Angioplasty Outcomes
11. Discharge Time After Angioplasty Varies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... Ron ... an option to senior, upper-level executives speaking at a business luncheon today, "It ... high-level executive is an asset to be fully realized and activated by the ...
(Date:9/25/2017)... ... September 25, 2017 , ... “Renew Refresh Restore Reward”: is a ... Reward” is the creation of published author, Deborah Freeman, cofounded the Free Spirit Bible ... we returned to our cars, my sister-in-law invited us to come over before the ...
(Date:9/25/2017)... September 25, 2017 - Orlando, FL, Microsoft Ignite Conference (PRWEB) , ... ... ... Hosts, Inc . announced today that they have teamed up to deliver Netmail’s Hadron ... on-demand service from a HIPAA/HITRUST compliant Azure Cloud. Netmail will be demo-ing their Hadron ...
(Date:9/25/2017)... ... ... Ash Borers kill Ash trees in as little as 1-3 years. The signs ... by Rob Nagy, ISA Certified Arborist at Giroud Tree and Lawn, shows a street in ... signs of decline from Emerald Ash Borers, two Ash trees continue to thrive. ...
(Date:9/24/2017)... & Caicos Islands, BWI (PRWEB) , ... September 25, 2017 , ... ... to announce the resort is re-opening on October 1st. And, throughout the month ... three bedroom oceanfront rentals. , Hurricane Irma and Maria have passed and damage ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology: